Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferinject and Epoietin Zeta for Cancer-Related Anemia (FERASE)
NCT02213653Phase 4Terminated
- Sponsor
- Centre François Baclesse
- Start
- Apr 2013
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ferric carboxymaltose in anemia, sponsored by Centre François Baclesse. Started Apr 2013; status: terminated.
02
Drugs
ferric carboxymaltose
03
Conditions
anemia
Beyond the preview
Go deeper on NCT02213653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02213653.